chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the following day after vaccination 13Mar2021 in the evening my face became prickly and red. It felt like severe wind burn but I had not been outdoors. It passed within three hours; On the following day after vaccination 13Mar2021 in the evening my face became prickly and red. It felt like severe wind burn but I had not been outdoors. It passed within three hours; On the following day after vaccination 13Mar2021 in the evening my face became prickly and red. It felt like severe wind burn but I had not been outdoors. It passed within three hours; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 44-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Formulation: Solution for injection, Lot number: EN6207), dose 1 via an unspecified route of administration, administered in Arm Right on 12Mar2021 12:00 pm (at age of 44 years) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took codeine and experienced drug hypersensitivity (known allergies Codeine). She was not pregnant. She did not receive any other vaccine in four weeks. Prior to vaccination she had not tested positive for COVID. She did not had COVID post vaccination. The patient experienced on the following day after vaccination 13Mar2021 in the evening my face became prickly and red. It felt like severe wind burn but I had not been outdoors. It passed within three hours on 13Mar2021 18:30. No treatment received for adverse event. The outcome of the events was recovered on an unspecified in Mar2021.  No follow-up attempts are possible. No further information is expected.
i gave the vaccine and asked the patient to wait 15min and to let me know if she felt any reaction post vaccination.  about 10 min after the vaccine patient complained of feelling swelling in her throat but denied any trouble breathing. she stated she was a retired nurse and didn't think her reaction was anaphylaxis.  i gave her 50mg of liquid diphenhydramine, gargled and swallowed.  i stayed with her for 10 minutes afterward and she said she was feeling less of a sensation in her throat.  she stayed an additional 10 min after.  i checked on her today and she experienced no additional problems after leaving
localized erythema, mild edema, discomfot, and localized urticaria spanning appx 8 cm x 18 cm over site of injection
Prolonged sinus tachycardia, diagnosed with inappropriate sinus tachycardia
Rash that break out over her body; Itching; This is a spontaneous report from a contactable consumer or other non HCP. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection in pre-filled syringe, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2 SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection in pre-filled syringe, Batch/Lot number was not reported), dose 1, via an unspecified route of administration on an unspecified date as DOSE 1 SINGLE for covid-19 immunization. On an unknown date, reporter mentioned that she got yesterday the second dose of the Pfizer covid vaccine and at night after dinner she got some rash that break out over her body and gave her itching. She would like to know if this was an adverse event of the vaccine and what could she do about it. She mentioned that she took an allergy pill. Therapeutic measures were taken as a result of rash that break out over her body, itching. The outcome of all events was unknown.   No follow-up attempts are needed: information about lot/batch number cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 73-year-old male patient received BNT162b2 (BNT162B2), on 02Feb2021 as dose 1, single (Batch/Lot number: unknown), on 23Feb2021 as dose 2, single (Batch/Lot number: unknown), on 28Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 19Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Hyperlipidemia" (unspecified if ongoing); "asthma" (unspecified if ongoing); "DVT" (unspecified if ongoing); "Melanoma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (14Jul2022) Positive. Therapeutic measures were taken as a result of covid-19, vaccination failure.  Clinical course: The patient didn't received any other medications within two weeks prior to vaccination. The patient was not having any known allergies. On 14Jul2022 at 08:00, the patient experienced nasal congestion, fever, shortness of breath, positive Covid-19 antigen testing. Patient was given Paxlovid for COVID 19 treatment with therapy start date as 30Jun2022 and stop date as 05Jul2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors, however a contributory role of the suspect drug BNT162B2  to the reported events Vaccination failure and COVID-19 cannot be ruled out.
Fever resolved in  24 hours, red itchy painful 2" diameter rash, brain fog, cellulitis outer bicep
pt recv vax 6/97 & in 6/98 pt exp ``very severe'' chickenpox
Soreness in arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Soreness in arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness in arm). At the time of the report, VACCINATION SITE PAIN (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment information not provided  Company comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-002685 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.
On 2/21 the patient presented to the ED with a c/o chest pain. She was ultimately discovered to have a submassive pulmonary embolism. She was admitted 2/21-2/24. There was no known instigating factor for her PE, it is currently determined to be unprovoked. Malignancy evaluation has been negative. She was treated with heparin drip and is now on apixaban daily for an unknown period of time, potentially lifetime. Hematology consultation is pending.
post vaccination pericarditis and myocarditis from chest pain that developed within minutes of vaccination.
pt recvd 1st dose of Engerix-B & devel nausea & vomiting which resolved w/in 24-48 hrs p/inject; pt then devel pain in elbow that radiates up & down arm;
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.         Concomitant medications details were not reported by the reporter.  It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.   Treatment details were not reported by the reporter.  This case was considered for the 34th adult patient out of 190 reported who was received the vaccine.
Same day as 1st vaccine shot I started getting nauseous after dinner. The next morning I woke up with dizziness, nausea, and muffled hearing in my left ear. The 2nd morning after the vaccine shot my left ear was almost completely muffled and the sounds I did hear were frequency distorted to the point I could not understand verbal speech from that ear. During the course of that day my right ear started getting muffled also. The night between the 2nd and 3rd day after the vaccine shot I woke up around 2 am with a severe case of vertigo while laying flat on my back in bed. I immediately felt hot all over and my entire body started sweating. I attempted to do an Epley maneuver with partial success. I eventually got up and took a Zertec-D and tried a second Epley maneuver on the floor in the living room. I was not able to go back to sleep and I made it through the day and the next night by taking another Zertec-D before bedtime.  The 4th day after the vaccine shot I did not take any medications and just stayed in bed or in a recliner all day. The night between the 4th and 5th day after the shot I again woke up around 3am with the worst vertigo ever and by 6am I told my wife I needed to go to the hospital. During the whole time the dizziness and nausea never abated. I was checked into Hospital on the morning of the 5th day after taking the vaccine shot and was transported to  in  for an MRI.
Numbness around my mouth and my jaws wants to lock up like headache; Numbness around my mouth and my jaws wants to lock up like headache; Numbness around my mouth and my jaws wants to lock up like headache; This is a spontaneous report from a contactable healthcare professional. A 39-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK4176), via an unspecified route of administration on 08Jan2021 at a single dose for covid-19 immunisation. Medical history included anxiety and some depression. Concomitant medication included sertraline hydrochloride (ZOLOFT) for anxiety and some depression, clonazepam for anxiety when it gets extreme. On an unspecified date in Jan2021, the patient experienced numbness around her mouth and her jaws wants to lock up like headache. The patient received ibuprofen, Tylenol and Advil as treatment for the event. The patient is due to receive second dose on 29Jan2021. The outcome of the events was unknown.
Red itchy rash on chest; This is a spontaneous report from a contactable nurse, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 10:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, cervical disc herniation and urticaria. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), metoprolol (MANUFACTURER UNKNOWN), cyclobenzaprine hydrochloride (FLEXERIL) and hydroxyzine (MANUFACTURER UNKNOWN) and mul (as reported); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) and vancomycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 13Apr2021 at 22:15, approximately 12 hours after receiving vaccine, the patient experienced red itchy rash on chest. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with diphenhydramine (BENADRYL) and the patient got relieved by taking it. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red itchy rash on chest was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
parent noted for 2 days p/receiving vax discomfort upper body-states pt had sore joints all over but especially arms & shoulders; 26DEC92 & 27DEC92 noted shrill crying 10 mins duration q 2 hrs; pt given APAP; parents never took pts temp;
her arm is sore after getting her flu and COVID vaccines yesterday; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NUS2022US241636_NS. A 57-year-old female patient received BNT162b2 (BNT162B2), on 19Dec2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 57 years, in arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 19Dec2022 as dose number unknown, single (Batch/Lot number: unknown), in arm. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 19Dec2022, outcome "unknown", described as "her arm is sore after getting her flu and COVID vaccines yesterday".  Additional information: patient shared that her arm was sore after getting her flu and COVID vaccines yesterday.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. On 19-DEC-2012 the patient was vaccinated with ZOSTAVAX, 1 DF, (route unknown), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 27-JUN-2016 the patient was treated by a physician for the onset of a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
High fever, extreme fatigue, slept over 30 hours, chest pains, chills, no energy, sore throat, both diarrhea and vomiting for about 24 hrs, excruciating headache for three days
Systemic: Bell's Palsy-Severe, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Tinnitus-Severe, Systemic: Unable to Sleep-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: Patients' entire right face is drooping, with lack of mobility. Patient cannot blink which is causing additional issues, such as the visual changes. As of this morning patient has experienced some tingling to her face but she states it has not state consistent. She has difficulty eating and sleeping. Patient is also experiencing moderate to severe anxiety about the entire ordeal. Ringing in ear is constant and has not subsided since thursday (4/1). still experiencing symptoms since last week
This spontaneous report as received from a healthcare worker (also reported as medical assistant) refers to a 21 year old patient. No medical history and concurrent conditions were reported. On 12-OCT-2016 the adult patient was vaccinated with a 1 pediatric dose of 0.5 ml dose VAQTA (lot number M007124, expiry date 20-OCT-2017) (dosing regimen and frequency unknown) for an unknown indication. No concomitant medications were reported. No adverse effects were reported. The action taken and the outcome of the events was unknown. There was no product quality complaint reported. This case is linked to case number 1611USA003754 via same reporter link. Additional information has been requested.
Information has been received by a physician concerning a 8 year old pt who on 08/24/1996 was vaccinated with a dose of varicella virus vaccine live. ON 05/31/2002 the pt experienced a case of breakthrough varicella. There were less than 50 lesions. Unspecified  medical attention was sought, but there was no Tx or hospitalization. The pt recovered. No product quality complaint was involved. This is one pt out of 40 reported. Thirty nine other cases (WAES 0407USA01446 and 0409USA01855 through 0409USA01872 and 0409USA01874 through 0409USA01893) experienced breakthrough varicella after vacciantion with varicella virus vaccien live.. Additional information is not expected.
Pt reported to clinic RN that on date VAERS report filed that on 6/21/22 she experience an episode of Afib lasting about 3.5 hours.
Low grade temp, vomiting, severe headache, fatigue. Symptoms started to improve after 24 hrs. All symptoms were gone after 36 hrs of first symptoms.
passing out; epileptic seizure; hypotension; shivering; This case was reported by a nurse via call center representative and described the occurrence of passed out in a 44-year-old female patient who received HBV (Engerix B) (batch number F73DG, expiry date 3rd July 2023) for prophylaxis.   The patient's past medical history included adverse drug reaction.   On 14th March 2022, the patient received Engerix B. In March 2022, less than 3 weeks after receiving Engerix B, the patient experienced passed out (serious criteria GSK medically significant), epileptic seizure (serious criteria GSK medically significant), hypotension and shivering. On an unknown date, the outcome of the passed out, epileptic seizure, hypotension and shivering were unknown.   It was unknown if the reporter considered the passed out, epileptic seizure, hypotension and shivering to be related to Engerix B.     Additional Information: GSK Receipt Date: 28-Mar-2022 Reporter's Comments: The reporter stated that the patient passed out after being vaccinated with Engerix-B. The patient went to the emergency room, passed out again and was told that she had hypotension. The patient when returned to work, she was shivering, and the reporter stated that it seemed like an epileptic seizure. The patient had some reactions earlier after being injected with any medication, but never as severe as this episode. The reporter consented to follow-up. Additional Supportive Information: This case had been linked with US2022055946, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022055946:same reporter
Day after vaccine administered left under arm/pit swollen, painful to touch. Swelling and pain reduced after 3 days with Aleve.
2/15/2021, I started having off and on fatigue, increasing in severity with episodic ups and downs. Developed occasional frontal sinus, headaches,  post nasal drip, puffy eyes and brain fog. I still have not recovered. It is now worse than it was before it started.
I noticed on Sunday afternoon a suspicion of tinnitus volume. It was a mild increase and I thought it was a normal daily variant. However, on Monday morning when waking up, the volume was higher than normal. I see an acupuncturist normally for assisting in control with this. It?s usually at 2/10 but on Monday it was 4/10. I received acupuncture treatment on Monday and Tuesday. I also exercised and gained additional rest. Still on Wednesday the volume was 4/10. Thursday, I received more acupuncture, and the volume was still relatively high. Friday, it was still high even with sleep, acupuncture, and exercise. On Friday, I contacted an auto neurologist, and he recommended a hearing test. I scheduled a hearing test for that Friday afternoon. I also scheduled an appointment with my local ENT Friday as well. It showed a hearing loss of 20db loss at 8khz, 15db loss at 6khz, 15db loss at 4khz. My threshold was reported at 55 Db. And the year before was at 35 Db, which is a 20Db difference. The last audiogram I had was in June 2021. I had very stable hearing in the Spring consistently. When I consulted my ENT, he said it was very unusual hearing loss for a drop of 20 Db in one year. We discussed exposure to loud events. I attended a baseball game recently and I didn?t experience anything after that event. I only experienced the increased hearing after the vaccine. My ENT said it?s best to treat it as sensory neuro hearing loss. He prescribed a 10-day prednisone course 60mg for 6 days then reducing to 40mg then 20mg. He also recommended hyperbaric oxygen treatment which I?ll get a consultation for soon after the ENT notes have been sent. I have started taking additional supplements that are helpful for anti-inflammatory reasons. I?m taking resveratrol, omega 3, ubiquinol, rosemary and oregano oil. I?m continuing with acupuncture, so I went today, and I went in case it?s helpful. I?m waiting for my hyperbaric referral to come through. I may be seeing some incremental benefit from the prednisone. It was 3/10 on the tinnitus, but it?s hard to tell with normal daily variants. My next audiogram is next Monday July 25, and following up with an additional hearing test and see if there was any benefit from the steroid.
Pt stated they were anxious at seeing vaccinator assemble needle.  Vaccine given and pt reported tingling sensation down arm and then across chest.  Pt with vaso vagal response and unconscious for a few seconds, awoke sweaty, following commands.  Stated first vaccine he had tingling in lips.  EMS called and pt agreed to hospital transport.  VSWNL